Form 4: Procept BioRobotics EVP, CFO Kevin Waters Sells Shares to Cover Tax Obligations

Kevin Waters, EVP and CFO of Procept BioRobotics Corp, sold 733 shares of common stock on March 18, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On March 18, 2025, Kevin Waters, the EVP and CFO of Procept BioRobotics Corp, sold 733 shares of common stock.
• The sale was executed at a weighted average price of $57.06 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Waters directly owns 107,991 shares of Procept BioRobotics Corp.
• The sale was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a stock sale by an executive to cover tax obligations, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine sale of shares by an executive.

Key Dates

Keywords

Form 4, PROCEPT BioRobotics, Kevin Waters, Stock Sale, Executive Compensation, PRCT, Tax Withholding, Restricted Stock Units